Potential Role of Addiction Pharmacotherapy in Problematic Eating Behavior

Current Addiction Reports

Volumn 1, Issue 2, 2014, Pages 83-88

  Edge, Paula J ^a   Gold, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Anorexia nervosa; Behavioral addictions; Binge eating disorder; Brain reward system; Bulimia nervosa; Comorbidity; Eating disorder treatment; Food addiction; Withdrawal

Indexed keywords

EID: 84961878385     PISSN: None     EISSN: 21962952     Source Type: Journal    
DOI: 10.1007/s40429-014-0010-2     Document Type: Review

References (58)

1. Rossetti C, Spena G, Halfon O, Boutrel B. Evidence for a compulsive-like behavior in rats exposed to alternate access to highly preferred palatable food. Addict Biol. 2013. doi:10.1111/adb.12065.
2. Gearhardt AN, Corbin WR, Brownell KD. Food addiction: an examination of the diagnostic criteria for dependence. J Addict Med. 2009;3(1):1–7.
3. Gearhardt AN, Corbin WR. The role of food addiction in clinical research. Curr Pharm Des. 2011;17(12):1140–2.
4. Blum K, Oscar-Berman M, Barh D, Giordano J, Gold M. Dopamine genetics and function in food and substance abuse. J Genet Syndr Gene Ther. 2013. doi:10.4172/2157-7412.1000121.
5. Avena N, Rada P, Bocarsly ME, Hoebel BG. Binge eating as a form of addiction: evidence from an animal model of sugar addiction. In: Chambers N, editor. Binge eating: psychological factors, symptoms and treatment. New York: Nova; 2009. p. 95–123.
6. Avena NM. Food and addiction: implications and relevance to eating disorders and obesity. Curr Drug Abuse Rev. 2011;4(3):131–2.
7. Barry D, Grilo CM, Masheb RM. Comparison of patients with bulimia nervosa, obese patients with binge eating disorder, and nonobese patients with binge eating disorder. J Nerv Ment Dis. 2003;191(9):589–94.
8. Berner LA, Bocarsly ME, Hoebel BG, Avena NM. Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions. Curr Pharm Des. 2011;17(12):1180–7.
9. Gearhardt AN, White MA, Masheb RM, Grilo CM. An examination of food addiction in a racially diverse sample of obese patients with binge eating disorder in primary care settings. Compr Psychiatry. 2013;54(5):500–5. doi:10.1016/j.comppsych.2012.12.009.
10. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci. 2012;11:1–24. doi:10.1007/7854_2011_169.
11. Herzog DB, Eddy KT. Eating disorders: what are the risks? J Am Acad Child Adolesc Psychiatry. 2009;48(8):782–3. doi:10.1097/CHI.0b013e3181aa03d7.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.
13. Avena NM. The study of food addiction using animal models of binge eating. Appetite. 2010;55(3):734–7.
14. Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale Food Addiction Scale. Appetite. 2009;52(2):430–6.
15. Avena NM, Bocarsly ME, Hoebel BG, Gold MS. Overlaps in the nosology of substance abuse and overeating: the translational implications of “food addiction”. Curr Drug Abuse Rev. 2011;4(3):133–9. This article discusses what happens when the brain pathways for motivation and reinforcement become dysregulated and the neurochemical evidence of reward-related brain dysfunctions in BED, BN, and AN.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 2000.
17. Colantuoni C, Schwenker J, McCarthy J, Rada P, Ladenheim B, Cadet JL, et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport. 2001;12(16):3549–52.
18. Davis C, Carter JC. Compulsive overeating as an addiction disorder. A review of theory and evidence. Appetite. 2009;53(1):1–8.
19. Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Bio Rev. 1985;9:469–77.
20. Avena NM, Gold JA, Kroll C, Gold MS. Further developments in the neurobiology of food and addiction: update on the state of the science. Nutrition. 2012;28(4):341–3. doi:10.1016/j.nut.2011.11.002.
21. Avena NM, Bocarsly ME. Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa. Neuropharmacology. 2012;63(1):87–96. doi:10.1016/j.neuropharm.2011.11.010.
22. Stice E, Yokum S, Zald D, Dagher A. Dopamine-based reward circuitry responsivity, genetics, and overeating. Curr Top Behav Neurosci. 2011;6:81–93. doi:10.1007/7854_2010_89.
23. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010;13(5):635–41.
24. Gearhardt AN, Yokum S, Orr PT, Stice E, Corbin WR, Brownell KD. Neural correlates of food addiction. Arch Gen Psychiatry. 2011;68(8):808–16. doi:10.1001/archgenpsychiatry.2011.32.
25. Blum K, Liu Y, Shriner R, Gold MS. Reward circuitry dopaminergic activation regulates food and drug craving behavior. Curr Pharm Des. 2011;17(12):1158–67.
26. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B. 2008;363(1507):3191–200.
27. Edge PJ, Gold MS. Drug withdrawal and hyperphagia: lessons from tobacco and other drugs. Curr Pharm Des. 2011;17(12):1173–9.
28. Blum K, Bailey J, Gonzalez AM, Oscar-Berman M, Liu Y, Giordano J, Braverman E, Gold M Neuro-genetics of reward deficiency syndrome (Rds) as the root cause of “addiction transfer”: a new phenomenon common after bariatric surgery. J Genet Syndr Gene Ther. 2011. doi:10.4172/2157-7412.S2-001.
29. Conason A, Teixeira J, Hsu CH, Puma L, Knafo D, Geliebter A. Substance use following bariatric weight loss surgery. JAMA Surg. 2013;148(2):145–50. doi:10.1001/2013.jamasurg.265.
30. Hajnal A, Zharikov A, Polston JE, Fields MR, Tomasko J, Rogers AM, et al. Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. PLoS One. 2012;7(11):e49121. doi:10.1371/journal.pone.0049121.
31. King WC, Chen JY, Mitchell JE, Kalarchian MA, Steffen KJ, Engel SG, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516–25. doi:10.1001/jama.2012.6147.
32. Dupont R, Gold MS. Withdrawal and reward: implications for detoxification and relapse prevention. Psychiatr Ann. 1995;25:663–8.
33. Barry D, Petry NM. Associations between body mass index and substance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addict Behav. 2009;34(1):51–60. doi:10.1016/j.addbeh.2008.08.008.
34. Shriner RL, Graham NA, Gold MS. Smoking cessation and the risk for type 2 diabetes mellitus. Ann Intern Med. 2010;152(11):755, author reply 755-6.
35. Anzengruber D, Klump KL, Thornton L, Brandt H, Crawford S, Fichter MM, et al. Smoking in eating disorders. Eat Behav. 2006;7(4):291–9.
36. Kirkham TC. Cannabinoids and appetite: food craving and food pleasure. Int Rev Psychiatr. 2009;21(2):163–71. doi:10.1080/09540260902782810.
37. Gold MS, Kobeissy FH, Wang KK, Merlo LJ, Bruijnzeel AW, Krasnova IN, et al. Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatry. 2009;66(2):118–27. doi:10.1016/j.biopsych.2009.02.021.
38. Jonas JM, Gold MS. Cocaine abuse and eating disorders. Lancet. 1986;1(8477):390–1.
39. Jonas JM, Gold MS. Naltrexone reverses bulimic symptoms. Lancet. 1986;1(8484):807.
40. Jonas JM, Gold MS. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Psychiatry Res. 1988;24(2):195–9.
41. Franko DL, Dorer DJ, Keel PK, et al. How do eating disorders and alcohol use disorder influence each other? Int J Eat Disord. 2005;38:200–7.
42. Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP, Herzog DB. Interactions between eating disorders and drug abuse. J Nerv Ment Dis. 2008;196(7):556–61.
43. Frank GK, Bailer UF, Henry S, Wagner A. Kaye WH Neuroimaging studies in eating disorders. CNS Spectr. 2004;9(7):539–48.
44. Bailer UF, Kaye WH. A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Curr Drug Targets CNS Neurol Disord. 2003;2(1):53–9.
45. 2A receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology. 2004;29(6):1143–55.
46. Lawson EA, Eddy KT, Donoho D, Misra M, Miller KK, Meenaghan E, et al. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol. 2011;164(2):253–61. doi:10.1530/EJE-10-0523.
47. Lawson EA, Holsen LM, Desanti R, Santin M, Meenaghan E, Herzog DB, et al. Increased hypothalamic-pituitary-adrenal drive is associated with decreased appetite and hypoactivation of food-motivation neurocircuitry in anorexia nervosa. Eur J Endocrinol. 2013;169(5):639–47. doi:10.1530/EJE-13-0433.
48. Avena NM, Gold MS. Food and addiction - sugars, fats and hedonic overeating. Addiction. 2011;106(7):1214–5. doi:10.1111/j.1360-0443.2011.03373.x, discussion 1219-20.
49. Colantuoni C, Rada P, McCarthy J, Patten C, Avena NM, Chadeayne A, et al. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res. 2002;10(6):478–88.
50. Avena NM, Rada P, Hoebel BG. Sugar and fat bingeing have notable differences in addictive-like behavior. J Nutr. 2009;139(3):623–8. doi:10.3945/jn.108.097584.
51. Berner LA, Avena NM, Hoebel BG. Bingeing, self-restriction, and increased body weight in rats with limited access to a sweet-fat diet. Obesity (Silver Spring). 2008;16(9):1998–2002.
52. Avena NM, Murray S, Gold MS. The next generation of obesity treatments: beyond suppressing appetite. Front Psychol. 2013;4:721. doi:10.3389/fpsyg.2013.00721.
53. Avena NM, Murray S, Gold MS. Comparing the effects of food restriction and overeating on brain reward systems. Exp Gerontol. 2013;48(10):1062–7. doi:10.1016/j.exger.2013.03.006.
54. Gold MS, Avena NM. Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating. Biol Psychiatry. 2013;74(7):e11. doi:10.1016/j.biopsych.2013.04.022.
55. Yarnell S, Oscar-Berman M, Avena N, Blum K, Gold M. Pharmacotherapies for overeating and obesity. J Genet Syndr Gene Ther 2013. doi:10.4172/2157-7412.1000131.
56. Blum K, Gardner E, Oscar-Berman M, Gold M. “Liking” and “wanting” linked to reward deficiency syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des. 2012;18(1):113–8.
57. Shriner RL, Gold MS. Treatment of overeating and obesity as an addiction. Dir Psychiatry. 2010;30(4):189–203.
58. Shriner RL, Gold MS. Current and future treatments of obesity. Dir Psychiatry. 2012;32(1):53–65.